These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38436988)

  • 1. ADHD Rating Scale (ADHD-RS): Validation in Spanish in adult population according to the DSM-5.
    Pereira A; Richarte V; Fadeuilhe C; Corrales M; García E; Ramos-Quiroga JA
    Span J Psychiatry Ment Health; 2024; 17(1):46-50. PubMed ID: 38436988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spanish validation of the adult Attention Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS): relevance of clinical subtypes.
    Richarte V; Corrales M; Pozuelo M; Serra-Pla J; Ibáñez P; Calvo E; Corominas M; Bosch R; Casas M; Ramos-Quiroga JA
    Rev Psiquiatr Salud Ment; 2017; 10(4):185-191. PubMed ID: 28844652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a Spanish-language version of the ADHD Rating Scale IV in a Spanish sample.
    Vallejo-Valdivielso M; Soutullo CA; de Castro-Manglano P; Marín-Méndez JJ; Díez-Suárez A
    Neurologia (Engl Ed); 2019; 34(9):563-572. PubMed ID: 28716394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale.
    Kessler RC; Green JG; Adler LA; Barkley RA; Chatterji S; Faraone SV; Finkelman M; Greenhill LL; Gruber MJ; Jewell M; Russo LJ; Sampson NA; Van Brunt DL
    Arch Gen Psychiatry; 2010 Nov; 67(11):1168-78. PubMed ID: 21041618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADHD in DSM-5: a field trial in a large, representative sample of 18- to 19-year-old adults.
    Matte B; Anselmi L; Salum GA; Kieling C; Gonçalves H; Menezes A; Grevet EH; Rohde LA
    Psychol Med; 2015 Jan; 45(2):361-73. PubMed ID: 25066615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5.
    Ustun B; Adler LA; Rudin C; Faraone SV; Spencer TJ; Berglund P; Gruber MJ; Kessler RC
    JAMA Psychiatry; 2017 May; 74(5):520-527. PubMed ID: 28384801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attention deficit hyperactivity disorder in adults. Benchmarking diagnosis using the Wender-Reimherr adult rating scale].
    Rösler M; Retz W; Retz-Junginger P; Stieglitz RD; Kessler H; Reimherr F; Wender PH
    Nervenarzt; 2008 Mar; 79(3):320-7. PubMed ID: 18210051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and reliability of the Turkish version of the adult ADHD Self-Report Screening Scale for DSM-5.
    Genç HA; Yorguner N; Bulut S; Bulut GC; Aydemir Ö; Yazgan Y
    Balkan Med J; 2021 Mar; 38(2):111-115. PubMed ID: 32996464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of Vanderbilt ADHD Parent Rating Scale in attention deficit hyperactivity disorder].
    Xiao ZH; Wang QH; Luo TT; Zhong L
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 May; 15(5):348-52. PubMed ID: 23676935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of Attention Deficit Hyperactivity Disorder in Intellectual Disability: Diagnostic and Statistical Manual of Mental Disorder V versus clinical impression.
    Perera B; Courtenay K; Solomou S; Borakati A; Strydom A
    J Intellect Disabil Res; 2020 Mar; 64(3):251-257. PubMed ID: 31808234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring DSM-5 ADHD criteria beyond young adulthood: phenomenology, psychometric properties and prevalence in a large three-decade birth cohort.
    Vitola ES; Bau CH; Salum GA; Horta BL; Quevedo L; Barros FC; Pinheiro RT; Kieling C; Rohde LA; Grevet EH
    Psychol Med; 2017 Mar; 47(4):744-754. PubMed ID: 27866484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Validity of the World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition in Adolescence.
    Somma A; Adler LA; Gialdi G; Arteconi M; Cotilli E; Fossati A
    J Child Adolesc Psychopharmacol; 2021 Nov; 31(9):631-638. PubMed ID: 34166067
    [No Abstract]   [Full Text] [Related]  

  • 13. [The predictive value of DSM-IV criteria in the diagnosis of attention deficit hyperactivity disorder and its cultural differences].
    Cardo E; Bustillo M; Servera M
    Rev Neurol; 2007 Mar; 44 Suppl 2():S19-22. PubMed ID: 17347938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
    Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
    Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the Spanish version of the attention deficit hyperactivity disorder adult screening scale (ASRS v. 1.1): a novel scoring strategy].
    Ramos-Quiroga JA; Daigre C; Valero S; Bosch R; Gómez-Barros N; Nogueira M; Palomar G; Roncero C; Casas M
    Rev Neurol; 2009 May 1-15; 48(9):449-52. PubMed ID: 19396760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of ADHD diagnostic criteria in the Assessment System for Individuals with ADHD (ASIA): a Japanese semi-structured diagnostic interview.
    Takeda T; Tsuji Y; Uwatoko T; Kurita H
    BMC Psychiatry; 2015 Jun; 15():130. PubMed ID: 26092179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes.
    Willcutt EG; Nigg JT; Pennington BF; Solanto MV; Rohde LA; Tannock R; Loo SK; Carlson CL; McBurnett K; Lahey BB
    J Abnorm Psychol; 2012 Nov; 121(4):991-1010. PubMed ID: 22612200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months.
    Wang LJ; Huang YS; Chiang YL; Hsiao CC; Shang ZY; Chen CK
    BMC Psychiatry; 2011 Apr; 11():65. PubMed ID: 21504587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agreement between Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, and the proposed DSM-V attention deficit hyperactivity disorder diagnostic criteria: an exploratory study.
    Ghanizadeh A
    Compr Psychiatry; 2013 Jan; 54(1):7-10. PubMed ID: 22809622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.